(You can check out Codelesss work with Adonis Health to learn more about that side of the equation)
(NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the U.S
A recent unsupervised cluster analysis based on a broad range of circulating biomarkers found that higher levels of NT-proBNP identify a subgroup of HFpEF patients (who also shared higher levels of cardiac troponin) who are at the highest risk of death and/or HF hospitalisation (62.8% over a median follow-up of 21 months).14 In the acute setting, NT-proBNP level is also considered a strong independent predictor of all-cause mortality, as recently described in the study by Lopuszynski et al
Online GLP-1 Programs Comparison How We Examined GLP-1 Suppliers With telehealth rapidly expanding, GLP-1 medications are becoming a central tool in managing weight and improving metabolic health
In the search for validating, science-backed solutions, researchers are increasingly focusing on the intersection of post-viral syndromes, gut health, and metabolic hormones